The most recent hard news is the report of October 13, 2026. Revenue rose 3.4% to USD 1.19 billion and diluted earnings per share rose 12.7% to USD 4.60, against published estimates of about USD 1.18 billion and USD 4.39. Underneath, U.S. same-store sales …
Exascale reported fiscal 2026 revenue of USD 14.82 million, up 111.3%, with a net loss of USD 12.16 million, and gave a business update on September 28 after its Nasdaq debut on August 27. With 91.20 million shares outstanding, theMarket Valueat USD 2.72 is …
Fabrinet is a contract manufacturer that builds optical communication components and also serves automotive, medical and industrial laser customers. Its model produces large revenue at modest margins: GAAP grossMarginwas 11.8% and non-GAAP was 12.1%, with non-GAAPOperating Marginat 10.8%.Operating Cash Flowwas only USD 21.3 million, …
Fermi is developing a power and data center campus known as Project Matador. ItsSubsidiaryFermi Campus 1 and TensorWave TEX1 signed a Data Center Lease and Services Agreement in August 2026, but the October 31 closing date passed without an extension and conditions were not …
Branded Retail sales fell 5.1% to USD 772.1 million and Other sales fell 4.0% to USD 397.0 million. Margin pressure came from lower production volumes, higher logistics andMarketingcosts and more outside product purchases. Third-quarter items included USD 4.6 million of restructuring charges, USD 1.5 …
Flywire runs a payment platform that moves tuition and other large cross-border payments for schools, healthcare and travel clients. Adjusted EBITDA rose 39.2% to USD 79.5 million, aMarginof 32.5%, up about 310 basis points. Income from operations was USD 52.8 million andDiluted Earnings per …
The stock has a record of explosive sessions around product news. On July 31, 2026 it was reported up more than 500% after the company launched a Deterministic AI Forms Auto-Populate Engine, an enterprise document platform meant to turn repetitive manual paperwork into automated …
The company completed a Phase 2b trial of GH001 in treatment-resistant depression in 2025. Its second-quarter 2026 report said two Phase 1 studies, including the study that opened the US investigational new drug application, were complete, and that doses for the pivotal program were …
The headline number is the guidance change. The full-year 2026 adjusted EBITDA outlook was reset to a floor of more than USD 40 million, down from USD 80 million to USD 100 million, with the summary citing first-half shortfalls, grossMarginpressure and higher research spending. …
Heartflow provides a platform that analyzes heart scans to assess coronary artery disease.GAAPgross margin rose to 83.6% from 76.5%, and non-GAAP gross margin to 83.8% from 76.8%. Adjusted EBITDA was a loss of USD 3.6 million against a loss of USD 9.8 million a …